Louise V. Wain

29.0k total citations · 1 hit paper
74 papers, 2.1k citations indexed

About

Louise V. Wain is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Molecular Biology. According to data from OpenAlex, Louise V. Wain has authored 74 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Pulmonary and Respiratory Medicine, 20 papers in Genetics and 14 papers in Molecular Biology. Recurrent topics in Louise V. Wain's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (22 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (18 papers) and Genetic Associations and Epidemiology (15 papers). Louise V. Wain is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (22 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (18 papers) and Genetic Associations and Epidemiology (15 papers). Louise V. Wain collaborates with scholars based in United Kingdom, United States and France. Louise V. Wain's co-authors include Martin D. Tobin, John A.L. Armour, Fran Van Heuverswyn, Beatrice H. Hahn, Paul M. Sharp, Frédéric Bibollet‐Ruche, Eitel Mpoudi Ngole, George M. Shaw, Jun Takehisa and Martine Peeters and has published in prestigious journals such as Science, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Louise V. Wain

67 papers receiving 2.0k citations

Hit Papers

Chimpanzee Reservoirs of Pandemic and Nonpandemic HIV-1 2006 2026 2012 2019 2006 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Chimpanzee Reservoirs of Pandemic and Nonpandemic HIV-1
    2006 555 citations Brandon F. Keele, Fran Van Heuverswyn et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Louise V. Wain United Kingdom 22 509 487 483 385 324 74 2.1k
R. Clark Brown United States 28 603 1.2× 104 0.2× 176 0.4× 289 0.8× 215 0.7× 104 2.5k
Wei Luo China 29 927 1.8× 373 0.8× 123 0.3× 245 0.6× 589 1.8× 107 3.0k
Susan E. Wilson United States 27 1.2k 2.4× 160 0.3× 193 0.4× 297 0.8× 238 0.7× 81 3.0k
Patricia A. Pioli United States 29 787 1.5× 216 0.4× 312 0.6× 112 0.3× 149 0.5× 51 2.9k
Jeff E. Mold Sweden 25 841 1.7× 181 0.4× 307 0.6× 578 1.5× 398 1.2× 41 3.8k
Robin Baker United States 22 214 0.4× 287 0.6× 201 0.4× 122 0.3× 188 0.6× 76 1.6k
Michio Yasunami Japan 33 1.4k 2.7× 203 0.4× 341 0.7× 238 0.6× 313 1.0× 99 3.3k
David Price United Kingdom 26 447 0.9× 317 0.7× 851 1.8× 81 0.2× 283 0.9× 106 2.9k
Matthew R. Lewin United States 26 588 1.2× 216 0.4× 925 1.9× 510 1.3× 88 0.3× 107 2.1k
Carmen Vidal Spain 30 121 0.2× 207 0.4× 177 0.4× 448 1.2× 419 1.3× 121 2.5k

Countries citing papers authored by Louise V. Wain

Since Specialization
Citations

This map shows the geographic impact of Louise V. Wain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louise V. Wain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louise V. Wain more than expected).

Fields of papers citing papers by Louise V. Wain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louise V. Wain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louise V. Wain. The network helps show where Louise V. Wain may publish in the future.

Co-authorship network of co-authors of Louise V. Wain

This figure shows the co-authorship network connecting the top 25 collaborators of Louise V. Wain. A scholar is included among the top collaborators of Louise V. Wain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louise V. Wain. Louise V. Wain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Valand, Arvind G, et al.. (2025). Interplay between genetics and epigenetics in lung fibrosis. The International Journal of Biochemistry & Cell Biology. 180. 106739–106739. 3 indexed citations
2.
Jenkins, Gísli, et al.. (2024). Review of codelists used to define hypertension in electronic health records and development of a codelist for research. Open Heart. 11(1). e002640–e002640. 1 indexed citations
3.
Moss, Samuel, Cosetta Minelli, Olivia C. Leavy, et al.. (2024). Assessing causal relationships between diabetes mellitus and idiopathic pulmonary fibrosis: a Mendelian randomisation study. Thorax. 80(3). 133–139. 3 indexed citations
4.
Leavy, Olivia C., Letícia Kawano-Dourado, Iain Stewart, et al.. (2024). Rheumatoid arthritis and idiopathic pulmonary fibrosis: a bidirectional Mendelian randomisation study. Thorax. 79(6). 538–544. 7 indexed citations
5.
Allen, Richard J., et al.. (2023). Shared genetic risk factors: implications for treatment of idiopathic pulmonary fibrosis and systemic hypertension. ERJ Open Research. 9(6). 457–2023. 1 indexed citations
6.
Allen, Richard J., Olivia C. Leavy, Nicholas M. Selby, et al.. (2023). Classifying the unclassifiable—a Delphi study to reach consensus on the fibrotic nature of diseases. QJM. 116(6). 429–435. 3 indexed citations
7.
Reynolds, Carl, Fabiola Del Greco M, Richard J. Allen, et al.. (2023). The causal relationship between gastro-oesophageal reflux disease and idiopathic pulmonary fibrosis: a bidirectional two-sample Mendelian randomisation study. European Respiratory Journal. 61(5). 2201585–2201585. 32 indexed citations
8.
Packer, Richard, William Hennah, Nick Shrine, et al.. (2023). DeepPheWAS: an R package for phenotype generation and association analysis for phenome-wide association studies. Bioinformatics. 39(4). 6 indexed citations
9.
Leavy, Olivia C., Richard J. Allen, Luke M. Kraven, et al.. (2022). The Use of Genetic Information to Define Idiopathic Pulmonary Fibrosis in UK Biobank. CHEST Journal. 163(2). 362–365. 4 indexed citations
10.
Zheng, Bang, Luke Daines, Qing Han, et al.. (2022). Prevalence, risk factors and treatments for post-COVID-19 breathlessness: a systematic review and meta-analysis. European Respiratory Review. 31(166). 220071–220071. 35 indexed citations
11.
Allen, Richard J., Amy Stockwell, Justin M. Oldham, et al.. (2022). Genome-wide association study across five cohorts identifies five novel loci associated with idiopathic pulmonary fibrosis. Thorax. 77(8). 829–833. 56 indexed citations
12.
13.
Kraven, Luke M., Adam Taylor, Philip L. Molyneaux, et al.. (2022). Cluster analysis of transcriptomic datasets to identify endotypes of idiopathic pulmonary fibrosis. Thorax. 78(6). 551–558. 14 indexed citations
14.
Fadista, João, Luke M. Kraven, Juha Karjalainen, et al.. (2021). Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity. EBioMedicine. 65. 103277–103277. 58 indexed citations
15.
16.
Nakanishi, Tomoko, Agustin Cerani, Vincenzo Forgetta, et al.. (2021). Genetically increased circulating FUT3 level leads to reduced risk of idiopathic pulmonary fibrosis: a Mendelian randomisation study. European Respiratory Journal. 59(2). 2003979–2003979. 12 indexed citations
17.
Fabbri, Chiara, Saskia P. Hagenaars, Catherine John, et al.. (2021). Genetic and clinical characteristics of treatment-resistant depression using primary care records in two UK cohorts. Molecular Psychiatry. 26(7). 3363–3373. 80 indexed citations
18.
Zeggini, Eleftheria, Anna L. Gloyn, Anne Barton, & Louise V. Wain. (2019). Translational genomics and precision medicine: Moving from the lab to the clinic. Science. 365(6460). 1409–1413. 109 indexed citations
19.
Artigas, María Soler, Louise V. Wain, Ma’en Obeidat, et al.. (2010). New Loci Associated with Lung Function and Chronic Obstructive Pulmonary Disease. Genetic Epidemiology. 34. 971–972.
20.
Keele, Brandon F., Fran Van Heuverswyn, Yingying Li, et al.. (2006). Chimpanzee Reservoirs of Pandemic and Nonpandemic HIV-1. Science. 313(5786). 523–526. 555 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Clark Brown Breakdown of academic impact, for papers by Wei Luo Breakdown of academic impact, for papers by Susan E. Wilson Breakdown of academic impact, for papers by Patricia A. Pioli Breakdown of academic impact, for papers by Jeff E. Mold Breakdown of academic impact, for papers by Robin Baker Breakdown of academic impact, for papers by Michio Yasunami Breakdown of academic impact, for papers by David Price Breakdown of academic impact, for papers by Matthew R. Lewin Breakdown of academic impact, for papers by Carmen Vidal
Rankless by CCL
2026